← Eichor
Condition: Epileptic Seizures Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Epileptic Seizures

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Phase 3 · 60 location(s) · Epygenix · NCT04462770Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04421846A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06092346A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Phase 3 · 11 location(s) · Praxis Precision Medicines · NCT07010471Clinical and Electrographic Changes in Responsive Neurostimulation System (RNS) Patients with Acupuncture Treatment
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT04677751Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clin
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT06362161Modulating Movement Intention Via Cortical Stimulation
NA · 1 location(s) · NYU Langone Health · NCT03233399Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
NA · 12 location(s) · Assistance Publique Hopitaux De Marseille · NCT05609084Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Phase 3 · 5 location(s) · Rapport Therapeutics Inc. · NCT07594119Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic
NA · 7 location(s) · Assistance Publique Hopitaux De Marseille · NCT06334952AI-Based Mobile Intervention on Medication Non-Adherence and Transition
NA · 2 location(s) · University of Central Florida · NCT07445074Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs
NA · 1 location(s) · Duke University · NCT06545643Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Epileptic Patients With Hypovitaminosis
NA · 1 location(s) · Bangladesh Medical University · NCT07085598A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndro
Phase 1/Phase 2 · 14 location(s) · Encoded Therapeutics · NCT05419492Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement
NA · 1 location(s) · University Hospital, Bordeaux · NCT06241924Human Epilepsy Genetics--Neuronal Migration Disorders Study
Phase N/A · 1 location(s) · Harvard University Faculty of Medicine · NCT00041600Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
Phase N/A · 1 location(s) · Aziende Chimiche Riunite Angelini Francesco S.p.A · NCT06716801Registry and Natural History of Epilepsy-Dyskinesia Syndromes
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06967727Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
Phase N/A · 15 location(s) · Assistance Publique Hopitaux De Marseille · NCT04802135Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)
Phase 2/Phase 3 · 1 location(s) · Sohag University · NCT07095842SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Phase 2 · 1 location(s) · Supernus Pharmaceuticals, Inc. · NCT07141329Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06593951A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
Phase 4 · 1 location(s) · Affiliated Hospital of Nantong University · NCT06967012Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies
NA · 4 location(s) · Azienda Ospedaliero-Universitaria di Modena · NCT06855901A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Phase 2/Phase 3 · 124 location(s) · Biohaven Therapeutics Ltd. · NCT06132893Levetiracetam for Seizure Prevention After Brain Tumor Surgery
Phase 3 · 1 location(s) · Beijing Tiantan Hospital · NCT07239115Pharmacological Modulation of Brain Oscillations in Memory Processing
EARLY_Phase 1 · 1 location(s) · University of Texas Southwestern Medical Center · NCT05594017Status Epilepticus Population Study (STEPS)
Phase N/A · 2 location(s) · University Hospital, Basel, Switzerland · NCT04204863SLC6A1-NDD Prospective Longitudinal Natural History Study
Phase N/A · 3 location(s) · UCB Biopharma SRL · NCT07531511Retraining and Control Therapy (ReACT) R33 Phase
NA · 1 location(s) · University of Alabama at Birmingham · NCT06007053
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.